Literature DB >> 23216075

Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.

A K Lidehäll1, M-L Engman, F Sund, G Malm, I Lewensohn-Fuchs, U Ewald, T H Tötterman, E Karltorp, O Korsgren, B-M Eriksson.   

Abstract

Congenital cytomegalovirus (CMV) infection is the most common congenital infection causing childhood morbidity. The pathogenetic mechanisms behind long-term sequelae are unclear, but long-standing viremia as a consequence of the inability to convert the virus to a latent state has been suggested to be involved. Whereas primary CMV infection in adults is typically rapidly controlled by the immune system, children have been shown to excrete virus for years. Here, we compare T cell responses in children with congenital CMV infection, children with postnatal CMV infection and adults with symptomatic primary CMV infection. The study groups included 24 children with congenital CMV infection, 19 children with postnatal CMV infection and eight adults with primary CMV infection. Among the infants with congenital CMV infection, 13 were symptomatic. T cell responses were determined by analysis of interferon gamma production after stimulation with CMV antigen. Our results show that whereas adults display high CMV-specific CD4 T cell responses in the initial phase of the infection, children younger than 2 years have low or undetectable responses that appear to increase with time. There were no differences between groups with regard to CD8 T cell function. In conclusion, inadequate CD 4 T cell function seems to be involved in the failure to get immune control of the CMV infection in children younger than 2 years of age with congenital as well as postnatal CMV infection.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23216075     DOI: 10.1111/sji.12013

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  21 in total

1.  Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants.

Authors:  Isabelle Boucoiran; Bryan T Mayer; Elizabeth M Krantz; Arnaud Marchant; Sunil Pati; Suresh Boppana; Anna Wald; Larry Corey; Corey Casper; Joshua T Schiffer; Soren Gantt
Journal:  Pediatr Infect Dis J       Date:  2018-07       Impact factor: 2.129

2.  Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.

Authors:  Sharon F Chen; Tyson H Holmes; Teri Slifer; Vasavi Ramachandran; Sally Mackey; Cathleen Hebson; Ann M Arvin; David B Lewis; Cornelia L Dekker
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09-11       Impact factor: 3.164

3.  CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV-infected newborn mice.

Authors:  Ilija Brizić; Lea Hiršl; Marko Šustić; Mijo Golemac; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2019-03-28       Impact factor: 3.402

Review 4.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

5.  Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Authors:  Laura Gibson; Constance M Barysauskas; Margaret McManus; Sheryl Dooley; Daniele Lilleri; Donna Fisher; Tumul Srivastava; Don J Diamond; Katherine Luzuriaga
Journal:  J Clin Immunol       Date:  2015-02-25       Impact factor: 8.317

6.  Recommendations for Diagnosis and Prevention of Cytomegalovirus-Associated Necrotizing Enterocolitis in Breast-Fed Preterm Infants.

Authors:  Jennifer T Pham; Allison F Dahlgren; Phornphat Rasamimari
Journal:  J Pediatr Pharmacol Ther       Date:  2022-02-09

7.  A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.

Authors:  Vijayendra Dasari; Kirrilee Beckett; Shane Horsefield; George Ambalathingal; Rajiv Khanna
Journal:  PLoS Pathog       Date:  2022-06-23       Impact factor: 7.464

8.  Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants.

Authors:  Bryan T Mayer; Laura Matrajt; Corey Casper; Elizabeth M Krantz; Lawrence Corey; Anna Wald; Soren Gantt; Joshua T Schiffer
Journal:  J Infect Dis       Date:  2016-09-20       Impact factor: 5.226

Review 9.  Cytomegalovirus in the neonate: immune correlates of infection and protection.

Authors:  Mark R Schleiss
Journal:  Clin Dev Immunol       Date:  2013-08-19

Review 10.  CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature.

Authors:  Angela Chiereghin; Gabriella Verucchi; Tiziana Lazzarotto
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.